| HBMCX | RPMGX | HBMCX / RPMGX | |
| Total Expense Ratio | 1.01 | 0.77 | 131% |
| Annual Report Gross Expense Ratio | 1.01 | 0.77 | 131% |
| Fund Existence | 27 years | 34 years | - |
| Gain YTD | -7.012 | 0.062 | -11,363% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 647M | 20.8B | 3% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -14.31 | -5.63 | 254% |
| Returns for 3 years | -16.06 | -0.19 | 8,654% |
| Returns for 5 years | -47.87 | -24.20 | 198% |
| Returns for 10 years | -36.17 | 27.75 | -130% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GGOAX | 11.15 | 0.01 | +0.09% |
| Goldman Sachs Mid Cap Growth A | |||
| JOHAX | 29.76 | -0.01 | -0.03% |
| JOHCM International Select Investor | |||
| PRHSX | 94.44 | -0.31 | -0.33% |
| T. Rowe Price Health Sciences | |||
| THMEX | 16.85 | -0.07 | -0.41% |
| CCT Thematic Equity Institutional | |||
| BRSYX | 16.90 | -0.09 | -0.53% |
| MFS Blended Research Small Cap Eq R6 | |||